Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (141-150 of 427) with videos related to

Pageof 43
Sort By:
Clinical Colorectal Cancer|June 9, 2021
Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials GroupCatherine Dunn, Wei Hong, Peter Gibbs, et al.
Asia-Pacific Journal of Clinical Oncology|May 16, 2019
Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancerTimothy Price, Lin Shen, Brigette Ma, et al.
Journal of Pain and Symptom Management|July 5, 2014
Comparison of ECOG/WHO performance status and ASA score as a measure of functional statusJane Young, Tim Badgery-Parker, Timothy Dobbins, et al.
ANZ Journal of Surgery|August 6, 2014
Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results?William G Pollett, Peter Gibbs, Stephen McLaughlin, et al.
Journal of the National Cancer Institute|November 2, 2006
Re: Completion of therapy by Medicare patients with stage III colon cancerPeter Gibbs, Stephen McLaughlin, Iain Skinner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 10, 2019
Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphomaMarius E Mayerhoefer, Christopher C Riedl, Anita Kumar, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|November 4, 2015
Registration of Supine MR Mammography with Breast Ultrasound for Surgical Planning of Breast Conserving Surgery: A Feasibility StudyMartin D Pickles, Peter Gibbs, Anne Hubbard, et al.
Asia-Pacific Journal of Clinical Oncology|April 14, 2015
The rapidly escalating cost of treating colorectal cancer in AustraliaSumitra Ananda, Suzanne Kosmider, Ben Tran, et al.
NMR in Biomedicine|May 21, 2014
Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancerJose R Teruel, Mariann G Heldahl, Pål E Goa, et al.
ANZ Journal of Surgery|November 20, 2004
Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experienceBrett G M Hughes, Desmond Yip, Michael Chao, et al.
Pageof 43

Showing results (141-150 of 427) with videos related to

Sort By:
Pageof 43
Clinical Colorectal Cancer|June 9, 2021
Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials GroupCatherine Dunn, Wei Hong, Peter Gibbs, et al.
Asia-Pacific Journal of Clinical Oncology|May 16, 2019
Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancerTimothy Price, Lin Shen, Brigette Ma, et al.
Journal of Pain and Symptom Management|July 5, 2014
Comparison of ECOG/WHO performance status and ASA score as a measure of functional statusJane Young, Tim Badgery-Parker, Timothy Dobbins, et al.
ANZ Journal of Surgery|August 6, 2014
Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results?William G Pollett, Peter Gibbs, Stephen McLaughlin, et al.
Journal of the National Cancer Institute|November 2, 2006
Re: Completion of therapy by Medicare patients with stage III colon cancerPeter Gibbs, Stephen McLaughlin, Iain Skinner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 10, 2019
Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphomaMarius E Mayerhoefer, Christopher C Riedl, Anita Kumar, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|November 4, 2015
Registration of Supine MR Mammography with Breast Ultrasound for Surgical Planning of Breast Conserving Surgery: A Feasibility StudyMartin D Pickles, Peter Gibbs, Anne Hubbard, et al.
Asia-Pacific Journal of Clinical Oncology|April 14, 2015
The rapidly escalating cost of treating colorectal cancer in AustraliaSumitra Ananda, Suzanne Kosmider, Ben Tran, et al.
NMR in Biomedicine|May 21, 2014
Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancerJose R Teruel, Mariann G Heldahl, Pål E Goa, et al.
ANZ Journal of Surgery|November 20, 2004
Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experienceBrett G M Hughes, Desmond Yip, Michael Chao, et al.
Pageof 43